Imugene Limited (IUGNF)
OTCMKTS · Delayed Price · Currency is USD
0.1737
-0.0401 (-18.74%)
Aug 1, 2025, 12:35 PM EDT
Imugene Market Cap
Imugene has a market cap or net worth of $46.54 million as of August 1, 2025. Its market cap has decreased by -83.18% in one year.
Market Cap
46.54M
Enterprise Value
34.94M
Revenue
-1.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.17
Market Cap Chart
Since September 17, 2002, Imugene's market cap has increased from 4.04M to 46.54M, an increase of 1,052.32%. That is a compound annual growth rate of 11.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 46.54M | -72.67% |
| Dec 31, 2024 | 170.29M | -68.32% |
| Dec 29, 2023 | 537.56M | -15.06% |
| Dec 30, 2022 | 632.87M | -62.26% |
| Dec 31, 2021 | 1.68B | 358.47% |
| Dec 31, 2020 | 365.76M | 267.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 563.22M |
| Glass House Brands | 409.73M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.29M |
| Northwest Biotherapeutics | 351.67M |